Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/8/2025

Risk Assessment for HPV Transmission

Understanding HPV Infection and Transmission

  • Approximately 70% of new HPV infections clear within 1 year, and about 90% clear within 2 years, with a median duration of 8 months, according to the Centers for Disease Control and Prevention 1
  • Given that the man's last potential exposure was 17 months ago, he has exceeded the typical clearance window for most HPV infections, as reported by the Centers for Disease Control and Prevention 1
  • While the immune system clears HPV most of the time, in some persons HPV infection does not resolve and can remain dormant for years, as noted by the Centers for Disease Control and Prevention 2, 3

Impact of HPV Vaccination

  • Current HPV vaccines protect against HPV types 16 and 18, which cause approximately 70% of cervical cancers, plus additional high-risk types depending on vaccine formulation, according to the American Cancer Society 4

Diagnosis and Screening

  • No clinically validated test exists to determine if men have HPV infection, which is a fundamental limitation in assessing the man's current infection status, as reported by the Centers for Disease Control and Prevention 2, 3, 5
  • High-risk HPV types are typically asymptomatic in men, unlike genital warts (caused by low-risk types), as noted by the Centers for Disease Control and Prevention 2, 3

Risk Reduction Strategies

  • The American College of Obstetricians and Gynecologists recommends HPV vaccination as the most important preventive measure, with vaccination recommended for ages 9-26 years, and can be considered up to age 45 2, 3, 6
  • Consistent condom use provides partial protection, reducing the risk of cervical and vulvovaginal HPV infection by approximately 70% when used correctly and consistently, as reported by the Centers for Disease Control and Prevention 2, 3, 6
  • Regular cervical cancer screening remains essential, with routine screening guidelines and regular Pap tests, as recommended by the American Cancer Society 7, 6

Additional Considerations

  • The absolute risk of developing HPV-related cancer is extremely low, even if HPV transmission occurs, progression to cervical cancer typically takes decades and occurs in only a small percentage of persistent infections, as noted by the Centers for Disease Control and Prevention 1, 6
  • Most new HPV infections are transient and asymptomatic, causing no clinical problems and clearing spontaneously, as reported by the Centers for Disease Control and Prevention 1

REFERENCES

4

HPV Vaccine Comparison [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Management of Male Partners When Female Partners Test Positive for HPV [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Risk Assessment and Disclosure for Future Female Partners [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026